Stifel Maintains IGM Biosciences(IGMS.US) With Buy Rating, Raises Target Price to $27

Futu NewsNov 11 21:37 · Ratings

Express News | IGM Biosciences Inc : Stifel Raises Target Price to $27 From $25

BreakingsNov 11 21:14

RBC Capital Reaffirms Their Buy Rating on IGM Biosciences (IGMS)

TipRanksNov 11 19:47 · Ratings

Igm Biosciences: Navigating Financial Challenges Amidst Early-Stage Antibody Development

TipRanksNov 9 14:01

IGM Biosciences Shifts Focus to Autoimmunity

TipRanksNov 9 12:25

IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates

Zacks Nov 8 20:15